ELTX

Elicio Therapeutics, Inc.

Insider trading activity for Elicio Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 30 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Aug 31	Adams Julian	Director	AGRANT◆	21,750	—	—	—	Open the original filing on SEC.gov
Aug 31	Nissenson Allen	Director	AGRANT◆	21,750	—	—	—	Open the original filing on SEC.gov
Aug 31	Chudnovsky Yekaterina	Director, 10% Owner	AGRANT◆	21,750	—	—	—	Open the original filing on SEC.gov
Aug 31	Ashe Carol Gail	Director	AGRANT◆	21,750	—	—	—	Open the original filing on SEC.gov
Aug 31	Venkatesan Jay	Director	AGRANT◆	21,750	—	—	—	Open the original filing on SEC.gov
Aug 31	Wilson Karen J	Director	AGRANT◆	21,750	—	—	—	Open the original filing on SEC.gov
Aug 31	Ruffolo Robert R	Director	AGRANT◆	21,750	—	—	—	Open the original filing on SEC.gov
Jul 16	Shah Preetam	See Remarks	AGRANT◆	60,833	—	—	—	Open the original filing on SEC.gov
Jul 16	Haqq Christopher	See Remarks	AGRANT◆	64,643	—	—	—	Open the original filing on SEC.gov
Jul 16	DeMuth Peter	Chief Scientific Officer	AGRANT◆	52,832	—	—	—	Open the original filing on SEC.gov
Jul 16	Connelly Robert	CEO, President and…	AGRANT◆	186,944	—	—	—	Open the original filing on SEC.gov
Feb 2	Shah Preetam	See Remarks	AGRANT◆	47,900	—	—	—	Open the original filing on SEC.gov
Feb 2	Shah Preetam	See Remarks	AGRANT	24,000	—	—	—	Open the original filing on SEC.gov
Feb 2	Haqq Christopher	See Remarks	AGRANT◆	50,900	—	—	—	Open the original filing on SEC.gov
Feb 2	Haqq Christopher	See Remarks	AGRANT	25,400	—	—	+79.4%	Open the original filing on SEC.gov
Feb 2	DeMuth Peter	Chief Scientific Officer	AGRANT◆	41,600	—	—	—	Open the original filing on SEC.gov
Feb 2	DeMuth Peter	Chief Scientific Officer	AGRANT	20,800	—	—	+2,799%	Open the original filing on SEC.gov
Feb 2	Connelly Robert	CEO, President and…	AGRANT◆	147,200	—	—	—	Open the original filing on SEC.gov
Feb 2	Connelly Robert	CEO, President and…	AGRANT	73,600	—	—	+156.7%	Open the original filing on SEC.gov
Dec 9, 2025	DeMuth Peter	Chief Scientific Officer	MEXER◆	362	—	—	—	Open the original filing on SEC.gov
Dec 9, 2025	DeMuth Peter	Chief Scientific Officer	MEXER	362	$4.41	$1.6K	+95.0%	Open the original filing on SEC.gov
Jun 3, 2025	Chudnovsky Yekaterina	Director, 10% Owner	AGRANT◆	103,225	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Nissenson Allen	Director	AGRANT◆	7,900	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Venkatesan Jay	Director	AGRANT◆	7,900	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Wilson Karen J	Director	AGRANT◆	7,900	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Ruffolo Robert R	Director	AGRANT◆	7,900	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Chudnovsky Yekaterina	Director, 10% Owner	AGRANT◆	7,900	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Ashe Carol Gail	Director	AGRANT◆	7,900	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Adams Julian	Director	AGRANT◆	7,900	—	—	—	Open the original filing on SEC.gov
Apr 15, 2025	Shah Preetam	See Remarks	AGRANT◆	191,624	—	—	—	Open the original filing on SEC.gov

AGRANT◆—

Adams Julian · DirectorAug 31

21,750 sh

AGRANT◆—

Nissenson Allen · DirectorAug 31

21,750 sh

AGRANT◆—

Chudnovsky Yekaterina · Director, 10%…Aug 31

21,750 sh

AGRANT◆—

Ashe Carol Gail · DirectorAug 31

21,750 sh

AGRANT◆—

Venkatesan Jay · DirectorAug 31

21,750 sh

AGRANT◆—

Wilson Karen J · DirectorAug 31

21,750 sh

AGRANT◆—

Ruffolo Robert R · DirectorAug 31

21,750 sh

AGRANT◆—

Shah Preetam · See RemarksJul 16

60,833 sh

AGRANT◆—

Haqq Christopher · See RemarksJul 16

64,643 sh

AGRANT◆—

DeMuth Peter · Chief Scientific…Jul 16

52,832 sh

AGRANT◆—

Connelly Robert · CEO, President…Jul 16

186,944 sh

AGRANT◆—

Shah Preetam · See RemarksFeb 2

47,900 sh

AGRANT—

Shah Preetam · See RemarksFeb 2

24,000 sh

AGRANT◆—

Haqq Christopher · See RemarksFeb 2

50,900 sh

AGRANT—

Haqq Christopher · See RemarksFeb 2

25,400 sh · +79.4% own

AGRANT◆—

DeMuth Peter · Chief Scientific…Feb 2

41,600 sh

AGRANT—

DeMuth Peter · Chief Scientific…Feb 2

20,800 sh · +2,799% own

AGRANT◆—

Connelly Robert · CEO, President…Feb 2

147,200 sh

AGRANT—

Connelly Robert · CEO, President…Feb 2

73,600 sh · +156.7% own

MEXER◆—

DeMuth Peter · Chief Scientific…Dec 9, 2025

362 sh

MEXER$1.6K

DeMuth Peter · Chief Scientific…Dec 9, 2025

362 sh @ $4.41 · +95.0% own

AGRANT◆—

Chudnovsky Yekaterina · Director, 10%…Jun 3, 2025

103,225 sh

AGRANT◆—

Nissenson Allen · DirectorMay 19, 2025

7,900 sh

AGRANT◆—

Venkatesan Jay · DirectorMay 19, 2025

7,900 sh

AGRANT◆—

Wilson Karen J · DirectorMay 19, 2025

7,900 sh

AGRANT◆—

Ruffolo Robert R · DirectorMay 19, 2025

7,900 sh

AGRANT◆—

Chudnovsky Yekaterina · Director, 10%…May 19, 2025

7,900 sh

AGRANT◆—

Ashe Carol Gail · DirectorMay 19, 2025

7,900 sh

AGRANT◆—

Adams Julian · DirectorMay 19, 2025

7,900 sh

AGRANT◆—

Shah Preetam · See RemarksApr 15, 2025

191,624 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 25 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →